Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Scott

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Immunotherapy|March 15, 2011
Antibody-targeted nanoparticles for cancer therapyFrancois Fay, Christopher J Scott
Biochimie|March 30, 2010
Biologic protease inhibitors as novel therapeutic agentsChristopher J Scott, Clifford C Taggart
Therapeutics and Clinical Risk Management|May 14, 2008
The renaissance of fixed dose combinations: CombivirSimon D Portsmouth, Christopher J Scott
Nature Nanotechnology|June 14, 2023
Carbon nanotubes activate inflammatory signalling through binding to Siglec-14Michelle K Greene, Christopher J Scott
Drug Discovery Today. Technologies|December 17, 2018
Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapyMichael C Johnston, Christopher J Scott
Endocrinology|January 18, 2002
Selective regulation of glutamic decarboxylase isoform 65, but not isoform 67, in the bed nucleus of the stria terminalis and the preoptic area of the ewe brain across the estrous cycleSueli Pompolo, Christopher J Scott, Iain J Clarke
Biology of Reproduction|February 28, 2003
Neuronal inputs from the hypothalamus and brain stem to the medial preoptic area of the ram: neurochemical correlates and comparison to the eweChristopher J Scott, Iain J Clarke, Alan J Tilbrook
BMC Genomics|April 21, 2010
The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin clusterJames F Burrows, Christopher J Scott, James A Johnston
Cancers|December 24, 2021
Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy ResistanceMichelle K Greene, Michael C Johnston, Christopher J Scott
Molecular Aspects of Medicine|July 22, 2022
Cathepsin S (CTSS) activity in health and disease - A treasure trove of untapped clinical potentialPeter Smyth, Jutharat Sasiwachirangkul, Rich Williams, et al.
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Immunotherapy|March 15, 2011
Antibody-targeted nanoparticles for cancer therapyFrancois Fay, Christopher J Scott
Biochimie|March 30, 2010
Biologic protease inhibitors as novel therapeutic agentsChristopher J Scott, Clifford C Taggart
Therapeutics and Clinical Risk Management|May 14, 2008
The renaissance of fixed dose combinations: CombivirSimon D Portsmouth, Christopher J Scott
Nature Nanotechnology|June 14, 2023
Carbon nanotubes activate inflammatory signalling through binding to Siglec-14Michelle K Greene, Christopher J Scott
Drug Discovery Today. Technologies|December 17, 2018
Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapyMichael C Johnston, Christopher J Scott
Endocrinology|January 18, 2002
Selective regulation of glutamic decarboxylase isoform 65, but not isoform 67, in the bed nucleus of the stria terminalis and the preoptic area of the ewe brain across the estrous cycleSueli Pompolo, Christopher J Scott, Iain J Clarke
Biology of Reproduction|February 28, 2003
Neuronal inputs from the hypothalamus and brain stem to the medial preoptic area of the ram: neurochemical correlates and comparison to the eweChristopher J Scott, Iain J Clarke, Alan J Tilbrook
BMC Genomics|April 21, 2010
The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin clusterJames F Burrows, Christopher J Scott, James A Johnston
Cancers|December 24, 2021
Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy ResistanceMichelle K Greene, Michael C Johnston, Christopher J Scott
Molecular Aspects of Medicine|July 22, 2022
Cathepsin S (CTSS) activity in health and disease - A treasure trove of untapped clinical potentialPeter Smyth, Jutharat Sasiwachirangkul, Rich Williams, et al.
Pageof 14